← All stocks

Indaptus Therapeutics, Inc.

INDP No buying or selling
CIK 0001857044 #3996 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Meckler Jeffrey A
Co-Chief Executive Officer
229,929
$538.03K
Newman Michael James
CSO and Director
101,074
$236.51K
+106.8%
Linscott Walt Addison
Chief Operating Officer
54,426
$127.36K
+1,088,420%
Sassi Nir
Chief Financial Officer
26,758
$62.61K
Ben-Tzvi Avraham
Director
25,100
$58.73K
+25,000%

No percentages here. This company's share count has moved by a factor of 120.4 over the window, from 1,106,529 to 133,242,324 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 375,000
History held since 6 Aug 2021